Auto Amazon Links: No products found. Blocked by captcha.
Once regarded as a global leader in transplantation, the UK’s heart and lung transplant system has fallen behind other Western countries. Despite maintaining a steady rate of procedures over the past 30 years, the NHS has not seen an increase in the number of transplants carried out annually. Investigations reveal outdated technology, insufficient investment, and a brain drain among senior surgeons, alongside concerns voiced by patients regarding the quality of ongoing care.
Jodie Cantle’s experience illustrates these systemic challenges. Born with cystic fibrosis, she has just 9% lung function and relies entirely on an oxygen cylinder while awaiting a double lung transplant. Over seven years, she has been offered transplants 17 times, but each time the surgery was cancelled, sometimes due to unavailability of operating theatres or because the lungs were deemed unsuitable. “I feel the world is moving on without me,” Jodie explains, capturing the frustration faced by many patients stuck on long waiting lists.
The UK’s transplant system faces inefficiencies in the use of donated organs. While donation rates per capita are comparable to or better than those across parts of Europe, the NHS utilizes a smaller fraction of the hearts and lungs donated. Only about one in ten lungs and one in seven hearts received are actually transplanted, compared to much higher usage rates elsewhere. Experts point to a lack of modern technology, such as CT coronary angiogram machines, and reliance on outdated preservation methods like ice boxes, which can lead to organ damage and complications post-surgery. In contrast, centers like Glasgow, benefiting from extra funding, employ advanced equipment that keeps organs viable and improves acceptance rates.
Beyond transplantation, long-term patient outcomes in the UK fall short of global standards. Survival rates five years after heart or lung transplants remain low, placing the country behind leading nations. Ongoing care, crucial to prevent organ rejection and manage side effects from immunosuppressant medications, is often inconsistent. Zanib, a lung transplant recipient from Manchester, experienced serious kidney failure years after her surgery, underscoring the critical need for better follow-up services. While the government has pledged to push the NHS to adopt reforms envisioned earlier in the year, healthcare professionals insist that adequate funding and resources are essential to revitalize the transplant system and improve patient care
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found. Blocked by captcha.